ArticleIn vivo (Athens, Greece)

Weekly Cetuximab and Paclitaxel for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

Chihiro Fushimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.